Advanced mass spectrometry turns manufacturing risk into success

KBI Biopharma prevented a costly crisis in the biopharmaceutical manufacturing process by utilizing advanced mass spectrometry techniques. The issue arose when a batch of cell culture media used in drug production turned pink, signalling potential contamination. Through investigating and proving that this was due to a chemical transformation of vitamin B12, KBI Biopharma saved their client significant financial loss and production delays.